[go: up one dir, main page]

AR030554A1 - SIMILAR MOLECULES TO IL-17 RECEPTORS AND USES OF THE SAME - Google Patents

SIMILAR MOLECULES TO IL-17 RECEPTORS AND USES OF THE SAME

Info

Publication number
AR030554A1
AR030554A1 ARP010101203A ARP010101203A AR030554A1 AR 030554 A1 AR030554 A1 AR 030554A1 AR P010101203 A ARP010101203 A AR P010101203A AR P010101203 A ARP010101203 A AR P010101203A AR 030554 A1 AR030554 A1 AR 030554A1
Authority
AR
Argentina
Prior art keywords
receptors
same
similar molecules
polypeptides
methods
Prior art date
Application number
ARP010101203A
Other languages
Spanish (es)
Inventor
Shuqian Jing
Eugene Medlock
Richard Yeh
Scott M Silbiger
Gary S Elliot
Hung Q Nguyen
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of AR030554A1 publication Critical patent/AR030554A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Nuevos polipéptidos similares a receptores IL-17 y moléculas de ácido nucleico que los codifican. El invento también se refiere a vectores, células huésped, agonistas y antagonistas (incluyendo agentes enlazantes selectivos) y métodos para producir polipéptidos semejantes a receptores IL-17. También se proveen métodos para el tratamiento, diagnostico, mejora o prevencion de enfermedades con polipéptidos similares a receptores IL-17.New polypeptides similar to IL-17 receptors and nucleic acid molecules that encode them. The invention also relates to vectors, host cells, agonists and antagonists (including selective binding agents) and methods for producing IL-17 receptor-like polypeptides. Methods for the treatment, diagnosis, improvement or prevention of diseases with polypeptides similar to IL-17 receptors are also provided.

ARP010101203A 2000-03-16 2001-03-15 SIMILAR MOLECULES TO IL-17 RECEPTORS AND USES OF THE SAME AR030554A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US18992300P 2000-03-16 2000-03-16
US20420800P 2000-05-12 2000-05-12
US72323200A 2000-11-27 2000-11-27
US26615901P 2001-02-02 2001-02-02

Publications (1)

Publication Number Publication Date
AR030554A1 true AR030554A1 (en) 2003-08-27

Family

ID=27497823

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010101203A AR030554A1 (en) 2000-03-16 2001-03-15 SIMILAR MOLECULES TO IL-17 RECEPTORS AND USES OF THE SAME

Country Status (8)

Country Link
EP (1) EP1265924A2 (en)
JP (1) JP2003527117A (en)
AR (1) AR030554A1 (en)
AU (2) AU2001259029B2 (en)
CA (1) CA2401273A1 (en)
MX (1) MXPA02009024A (en)
TW (1) TWI322154B (en)
WO (1) WO2001068705A2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2333069A3 (en) 1998-05-15 2011-09-14 Genentech, Inc. Therapeutic uses of IL-17 homologous polypeptides
US7771719B1 (en) 2000-01-11 2010-08-10 Genentech, Inc. Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
US20040043397A1 (en) 2000-01-11 2004-03-04 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
DK1897947T3 (en) * 1999-12-23 2012-04-10 Genentech Inc IL-17 homologous polypeptides and their therapeutic uses
US7718397B2 (en) 2000-03-21 2010-05-18 Genentech, Inc. Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
US20030096969A1 (en) 2000-06-02 2003-05-22 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2007202616B2 (en) * 2000-06-22 2011-08-18 Amgen Inc. IL-17 Like Molecules and Uses Thereof
MXPA03003407A (en) 2000-10-18 2004-05-04 Immunex Corp Methods for treating rheumatoid arthritis using il-17 antagonists.
AU2003263751A1 (en) * 2002-08-05 2004-02-23 Eli Lilly And Company Novel proteins and their uses
EP2116616A3 (en) * 2002-09-11 2010-03-17 Genentech, Inc. Genes differentially expressed in activated T cells and uses thereof
AU2007235212A1 (en) * 2006-02-10 2007-10-18 Zymogenetics, Inc. Truncated IL-17RA soluble receptor and methods of using in inflammation
US7767206B2 (en) 2006-10-02 2010-08-03 Amgen Inc. Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto
WO2008067057A2 (en) * 2006-10-13 2008-06-05 The Regents Of The University Of California Cancer treatment
US8454955B2 (en) * 2007-11-28 2013-06-04 Riken Methods for treating allergic airway inflammation, airway hypersensitivity, and eosinophilia
KR20150002874A (en) 2008-05-05 2015-01-07 노비뮨 에스 에이 Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof
GB0905972D0 (en) * 2009-04-06 2009-05-20 Medical Res Council Antibodies against IL-17BR
SG175276A1 (en) 2009-05-05 2011-11-28 Novimmune Sa Anti-il-17f antibodies and methods of use thereof
EA031209B9 (en) 2010-01-15 2021-11-19 Кирин-Эмджен, Инк. Antibody pharmaceutical formulation for treating an inflammatory disease and methods of using same
AU2011235232B2 (en) * 2010-03-30 2015-05-21 Janssen Biotech Inc. Humanized IL-25 antibodies
WO2013116682A1 (en) 2012-02-02 2013-08-08 Ensemble Therapeutics Corporation Macrocyclic compounds for modulating il-17

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL83878A (en) 1987-09-13 1995-07-31 Yeda Res & Dev Soluble protein corresponding to tnf inhibitory protein its preparation and pharmaceutical compositions containing it
US4892538A (en) 1987-11-17 1990-01-09 Brown University Research Foundation In vivo delivery of neurotransmitters by implanted, encapsulated cells
US5106627A (en) 1987-11-17 1992-04-21 Brown University Research Foundation Neurological therapy devices
WO1989004838A1 (en) 1987-11-25 1989-06-01 Immunex Corporation Interleukin-1 receptors
US4968607A (en) 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
US5319071A (en) 1987-11-25 1994-06-07 Immunex Corporation Soluble interleukin-1 receptors
US5011472A (en) 1988-09-06 1991-04-30 Brown University Research Foundation Implantable delivery system for biological factors
IL95031A (en) 1989-07-18 2007-03-08 Amgen Inc Method for the production of a human recombinant tumor necrosis factor inhibitor
US5350683A (en) 1990-06-05 1994-09-27 Immunex Corporation DNA encoding type II interleukin-1 receptors
DE69233441T2 (en) 1991-04-26 2005-10-13 Osaka Bioscience Institute, Suita Human cell surface antigen encoding DNA
US5489743A (en) 1993-01-19 1996-02-06 Amgen Inc. Transgenic animal models for thrombocytopenia
US6664107B1 (en) 1993-05-26 2003-12-16 Ontario Cancer Institute, University Health Network CD45 disrupted nucleic acid
CA2161015A1 (en) 1993-05-26 1994-12-08 Tak Wah Mak Transgenic mammals lacking expression of particular cd45 isoforms
WO1995001997A1 (en) 1993-07-09 1995-01-19 Smithkline Beecham Corporation RECOMBINANT AND HUMANIZED IL-1β ANTIBODIES FOR TREATMENT OF IL-1 MEDIATED INFLAMMATORY DISORDERS IN MAN
MX9704780A (en) 1994-12-23 1998-05-31 Uab Research Foundation Secreted human fas antigen.
WO1996041865A1 (en) 1995-06-07 1996-12-27 Ariad Gene Therapeutics, Inc. Rapamcycin-based regulation of biological events
CA2244363C (en) 1996-02-28 2006-11-14 Ariad Gene Therapeutics, Inc. Synthetic derivatives of rapamycin as multimerizing agents for chimeric proteins with immunophilin-derived domains
US6482923B1 (en) * 1997-09-17 2002-11-19 Human Genome Sciences, Inc. Interleukin 17-like receptor protein
EP1015488B1 (en) * 1997-09-17 2009-09-09 Human Genome Sciences, Inc. Interleukin-17 receptor-like protein
JP2003502006A (en) * 1998-01-09 2003-01-21 イミュネックス・コーポレーション IL-17RH DNA and polypeptide
WO2000042187A1 (en) * 1999-01-11 2000-07-20 Schering Corporation Interleukin-17 related mammalian cytokine (il-171). polynucleotides encoding them. uses
AU4201000A (en) * 1999-04-05 2000-10-23 Incyte Pharmaceuticals, Inc. Molecules of the immune system
WO2001057202A2 (en) * 2000-02-04 2001-08-09 The Board Of Trustees Of The University Of Arkansas Evi27 gene sequences and protein encoded thereby
WO2001059120A2 (en) * 2000-02-08 2001-08-16 Amgen, Inc. Il-17 like molecules and uses thereof
US9100155B2 (en) 2010-05-03 2015-08-04 Qualcomm Incorporated Method and apparatus for control and data multiplexing in wireless communication
JP6160461B2 (en) 2013-11-29 2017-07-12 富士通株式会社 Likelihood weighting circuit

Also Published As

Publication number Publication date
AU2001259029B2 (en) 2006-01-05
MXPA02009024A (en) 2003-02-12
JP2003527117A (en) 2003-09-16
WO2001068705A3 (en) 2002-07-18
AU5902901A (en) 2001-09-24
TWI322154B (en) 2010-03-21
EP1265924A2 (en) 2002-12-18
WO2001068705A2 (en) 2001-09-20
CA2401273A1 (en) 2001-09-20

Similar Documents

Publication Publication Date Title
AR030236A1 (en) MOLECULES SIMILAR TO IL-17 AND USES OF THE SAME
AR030554A1 (en) SIMILAR MOLECULES TO IL-17 RECEPTORS AND USES OF THE SAME
EP1363632A4 (en) RECEPTOR SELECTIVE CANNABIMIMETIC AMINOALKYLINDOLS
NO20010062L (en) Biphenylsulfonamides as dual angiotensin-endothelin receptor antagonists
ECSP088508A (en) NEUROPILINE ANTAGONISTS
EA200501798A1 (en) NEW PEPTIDES THAT CONNECT WITH THE RECEPTOR TO ERYTHROPOIETIN
NO20030374D0 (en) Cyclopentanoindoles, preparations containing such compounds and treatment methods
EA200501430A1 (en) Cannabinoid receptor ligands and their use
BRPI0113286B8 (en) substituted pyrazoles and pharmaceutical composition comprising the same.
DK0817770T3 (en) Nonpeptides as tachykinin antagonists
EA200500520A1 (en) PURINE COMPOUNDS AND THEIR APPLICATION AS CANCELINOID RECEPTOR LIGANDS AS LIGANDS
NO20010446L (en) Substituted anilide compounds and methods
BR0208957A (en) 3,4-disubstituted cyclobutene-1,2-diones as cxc chemokine receptor ligands
DE69942459D1 (en) ISOLATED NUCLEIC ACID MOLECULES COPYING T CELLS INDUCIBLE FACTORS (TIF), ENCODING PROTEINS AND THEIR USE
DE60106954D1 (en) Resorcinol DERIVATIVES
ECSP066559A (en)
WO2001068859A3 (en) Il-17 receptor like molecules and uses thereof
AR028579A1 (en) METHOD FOR THE TREATMENT OF VAGINAL DROUGHT, WITH NICOTINIC ACETILCOLINE RECEPTOR AGONISTS
ECSP003707A (en) DIAZEPANES
TR199700956T1 (en) Indazole carboxamides.
ATE247130T1 (en) UROKINASE RECEPTOR INHIBITORS
ES2100051T3 (en) SYNTHESIS OF DIMER BLOCKS AND THEIR USE IN THE ASSEMBLY OF OLIGONUCLEOTIDES.
UY26265A1 (en) CALCIOLYTIC COMPOUNDS
DK1455770T3 (en) Use of norepinephrine uptake inhibitors for the treatment of tic disorders
AR023464A1 (en) NEW NOVELS OF THE OX2 PROTEIN OF MAMMER AND RELATED REAGENTS

Legal Events

Date Code Title Description
FB Suspension of granting procedure